Showing results (1-10 of 33) with videos related to
Sort By:
Pageof 4
Hematology. American Society of Hematology. Education Program|February 20, 2015
Treatment of relapsed classical Hodgkin lymphoma in the brentuximab vedotin eraSolomon A Graf, Ajay K GopalExpert Opinion on Pharmacotherapy|January 29, 2016
Idelalisib for the treatment of non-Hodgkin lymphomaSolomon A Graf, Ajay K GopalDrug Design, Development and Therapy|August 30, 2017
Anamorelin hydrochloride in the treatment of cancer anorexia-cachexia syndrome: design, development, and potential place in therapySolomon A Graf, Jose M GarciaExpert Opinion on Pharmacotherapy|September 18, 2018
On the front line: first choice pharmacotherapeutics for chronic lymphocytic leukemiaLaura S Samples, Solomon A GrafExpert Opinion on Pharmacotherapy|February 25, 2022
The evidence to date on umbralisib for the treatment of refractory marginal zone lymphoma and follicular lymphomaJanelle Schweitzer, Meghan Hoffman, Solomon A GrafExpert Opinion on Drug Discovery|February 8, 2025
The preclinical discovery and development of zanubrutinib for the treatment of chronic lymphocytic leukemiaTeri K Schleicher, Melanie Cohen, Solomon A GrafPharmaceuticals (Basel, Switzerland)|March 14, 2017
Targeted Drugs as Maintenance Therapy after Autologous Stem Cell Transplantation in Patients with Mantle Cell LymphomaFengting Yan, Ajay K Gopal, Solomon A GrafAmerican Journal of Hematology|October 13, 2006
PTPN22 620W allele is not associated with aplastic anemiaSolomon A Graf, Rodrigo T Calado, Neal S YoungHepatology Communications|August 8, 2019
Eradication of Hepatitis C Virus Is Associated With Reduction in Hematologic Malignancies: Major Differences Between Interferon and Direct-Acting AntiviralsGeorge N Ioannou, Pamela K Green, Kristin Berry, et al.Seminars in Oncology|October 14, 2019
Clinical research in older adults with hematologic malignancies: Opportunities for alignment in the Veterans AffairsSolomon A Graf, Laura S Samples, Tamarind M Keating, et al.Pageof 4